Used primarily as an intermediate in the synthesis of beta-blocker pharmaceuticals, particularly in the production of atenolol and related cardiovascular drugs. Its structure supports the development of selective β1-adrenergic receptor antagonists, which are critical in managing hypertension, angina, and certain cardiac arrhythmias. The compound's ether and amino alcohol functionalities enable key pharmacological activity by mimicking natural catecholamine structures while providing metabolic stability. It is also employed in research settings for developing new cardioselective agents and optimizing drug delivery systems for improved bioavailability.